Long-term survival of stage IV melanoma patients treated with a polyvalent, shed antigen, melanoma vaccine

被引：0
|
作者：
Laky, D
Shapiro, RL
Harris, MN
Roses, DF
Jacquotte, AZ
Reynolds, SR
Bystryn, J
机构：
[1] NYU, Sch Med, Kaplan Comprehens Canc Ctr, New York, NY USA
[2] NYU, Sch Med, Dept Surg, New York, NY USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2002年 / 119卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
198
引用
收藏
页码：240 / 240
页数：1
相关论文
共 50 条
  • [31] Long-term survival of patients with advanced melanoma treated with BRAF-MEK inhibitors
    Ismail, Rawa K.
    Suijkerbuijk, Karijn P. M.
    de Boer, Anthonius
    van Dartel, Maaike
    Hilarius, Doranne L.
    Pasmooij, A. M. G.
    van Zeijl, Michiel C. T.
    Aarts, Maureen J. B.
    van den Berkmortel, Franchette W. P. J.
    Blank, Christian U.
    Boers-Sonderen, Marye J.
    de Groot, Jan W. B.
    Haanen, John B. A. G.
    Hospers, Geke A. P.
    Kapiteijn, Ellen
    Piersma, Djura
    van Rijn, Rozemarijn S.
    van der Veldt, Astrid A. M.
    Vreugdenhil, Art
    Westgeest, Hans
    van den Eertwegh, Alfons J.
    Wouters, Michel W. J. M.
    MELANOMA RESEARCH, 2022, 32 (06) : 460 - 468
  • [32] Evaluation of survival in Japanese stage IV melanoma patients treated with melanoma antigen-pulsed mature monocyte-derived dendritic cells
    Nakai, Noriaki
    Katoh, Norito
    Kitagawa, Tomoko
    Ueda, Eiichiro
    Takenaka, Hideya
    Kishimoto, Saburo
    JOURNAL OF DERMATOLOGY, 2008, 35 (12): : 801 - 803
  • [33] Is the survival of melanoma patients receiving polyvalent melanoma cell vaccine linked to the human leukocyte antigen phenotype of patients? (vol 16, pg 1430, 1998)
    Hoon
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (06) : 2293 - 2293
  • [34] Improved survival in stage IB/II melanoma using Canvaxin™, a polyvalent cancer vaccine
    Faries, MB
    Foshag, LJ
    Essner, R
    Wanek, LA
    Morton, DL
    ANNALS OF SURGICAL ONCOLOGY, 2005, 12 (02) : S19 - S19
  • [35] PHASE-I TRIAL OF SPECIFIC IMMUNOTHERAPY OF MELANOMA WITH A POLYVALENT MELANOMA ANTIGEN VACCINE
    BYSTRYN, JC
    LEVIN, M
    SPEYER, S
    HARRIS, M
    ROSES, D
    BERNSTEIN, P
    CLINICAL RESEARCH, 1984, 32 (02): : A574 - A574
  • [36] Long-term survival and long-lived immune memory in patients with metastatic melanoma vaccinated with melanoma-antigen loaded dendritic cells
    Palucka, A. K.
    Ueno, H.
    Goldberg, G.
    Israyelyan, A.
    Marches, F.
    Bourdery, L.
    Fay, J. W.
    Banchereau, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [37] PHASE-I TRIAL OF SPECIFIC IMMUNOTHERAPY OF MELANOMA WITH A POLYVALENT MELANOMA ANTIGEN VACCINE
    BYSTTRYN, JC
    LEVIN, M
    SPEYER, S
    HARRIS, M
    ROSES, D
    BERNSTEIN, P
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1984, 82 (04) : 425 - 426
  • [38] Molecular staging in stage II and III melanoma patients and its effect on long-term survival
    Voit, C
    Kron, M
    Rademaker, J
    Schwürzer-Voit, M
    Sterry, W
    Weber, L
    Özdemir, C
    Proebstle, T
    Keilholz, U
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (06) : 1218 - 1227
  • [39] Long-term survival of patients with metastatic melanoma (MM) treated with dacarbazine (DTIC) or temozolomide (TMZ)
    Kim, C.
    Lee, C. W.
    Klasa, R.
    Shah, A.
    Savage, K. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [40] Long-Term Survival Shown for Advanced Melanoma Patients Treated with PD-1 Inhibitor
    Printz, Carrie
    CANCER, 2016, 122 (20) : 3100 - 3101
12345